FDA Inspection
Diversey Canada, Inc.Diversey Canada, Inc. – FDA Inspection, Nov 9, 2023
Record Details
This FDA Inspection record concerns Diversey Canada, Inc., with an inspection on November 9, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 71202672-aa9d-4ef7-b4c3-59f0d632b60d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222617
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Diversey Canada, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 22, 2016 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
Other documents for Diversey Canada, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.